AMFI - Registered Mutual Fund Distributor

Corona Remedies Limited IPO

Corona Remedies Limited IPO

₹ 14868 / 14 Shares Shares
Minimum Investment

Corona Remedies Limited IPO

Issues Price

₹1008-1062 per equity share

Corona Remedies Limited IPO

Open Date

08 Dec 2025

Close Date

10 Dec 2025

Lot Size

14

Min. Investment

₹ 14868

Issue Price

₹1008-1062

Listing Date

15 Dec 2025

Issues Size

61,71,101 shares(aggregating up to ₹655.37 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

14 Shares

Offered To Public

14 Shares

Corona Remedies Limited IPO

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women's healthcare, cardiology, pain management, urology, and other therapeutic areas. The diversified portfolio of the company as of December 2024 comprises 67 brands across therapeutic areas such as women's healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals, including vitamins/minerals/nutrition, gastrointestinal, and respiratory.The company has a pan-India marketing and distribution network with 2,598 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, thus consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas. Presently, the company owns two manufacturing facilities located in the states of Gujarat. As of December 31, 2024, the company had 88 R&D employees.

Founded In

2004

Managing Director

Dr. Kirtikumar Laxmidas Mehta

Parent Organization

Corona Remedies Limited IPO

Application Details of Corona Remedies Limited IPO.

Apply as Price Range Apply Upto
Retail (min) ₹1008-1062 ₹14,868
Retail(max) ₹1008-1062 ₹1,93,284
SHNI(min) ₹1008-1062 ₹2,08,152
SHNI(max) ₹1008-1062 ₹9,96,156
BHNI(min) ₹1008-1062 ₹10,11,024

For Corona Remedies Limited IPO, eligible investors can apply as Regular.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.7 Out of 5 (1689 Reviews)

I started SIPs with KSquare six months ago and already see consistent growth. Their timely updates and reports make tracking easy. Definitely a smart decision for financial planning.

Rajeev Nair

Rajeev Nair

Business Analyst

KSquare provided all the guidance I needed to start SIPs. Their plans fit my freelance income, and I’m seeing real results already!

Isha Reddy

Isha Reddy

Graphic Designer

KSquare presents each new fund launch with such clarity. Their tools gave me better understanding of sectors and fund outlooks before investing.

Harsh Vardhan

Harsh Vardhan

Energy Analyst

I was amazed by how quickly KSquare approved my loan. The entire system felt modern and very intuitive.

Tanya Deshmukh

Tanya Deshmukh

Clinical Therapist

I never thought mutual fund investing could be this simple. KSquare helps me manage risk and meet financial targets effortlessly. Great for working women like me.

Neha Bajaj

Neha Bajaj

Human Resource Lead

I was skeptical about loans on mutual funds, but KSquare provided full clarity and fast execution. Loved the experience!

Ishita Mehra

Ishita Mehra

Research Associate

I’m very happy with the NPS service at KSquare. Their personalized advice gave me the clarity I needed.

Namrata Das

Namrata Das

High School Teacher

KSquare’s NRI Corner was a game-changer for managing my Indian assets. Their process is smooth, transparent, and perfectly suited for NRIs like me.

Pooja Ramesh

Pooja Ramesh

Research Scientist

Investing used to feel intimidating, but KSquare has simplified everything. Their SIP plans offer great flexibility and peace of mind. I recommend them to all my colleagues.

Rohan Malhotra

Rohan Malhotra

Sales Executive

KSquare helped me borrow against my mutual funds with minimal paperwork. I’m impressed by their speed and support.

Anjali Sharma

Anjali Sharma

HR Executive

FAQ's

Frequenlty Asked Question

Why should I invest in mutual funds through KSquare?

KSquare offers expert-curated fund options, personalized recommendations, and a user-friendly platform to simplify mutual fund investing.

Is there a lock-in period for New Fund Offerings?

Open-ended NFOs usually have no lock-in, while close-ended ones might restrict withdrawals for a specific term.

Can I invest in an NFO online with KSquare?

Yes, KSquare’s digital platform enables secure and quick online investments in NFOs with just a few clicks.

What is a Loan Against Mutual Fund (LAMF)?

A Loan Against Mutual Fund allows you to borrow money by pledging your mutual fund units as collateral without selling your investments.

How does KSquare help in retirement planning?

KSquare builds long-term SIP strategies to create a secure retirement corpus based on future lifestyle, needs, and inflation.

Can I prepay the loan without penalties?

Most lenders allow prepayment without extra charges. KSquare ensures these terms are clearly shared before you proceed.

What documents are required to invest in mutual funds via KSquare?

You need a PAN card, Aadhaar, bank details, and address proof for KYC verification before starting investments.

Can I withdraw my mutual fund investment anytime?

Most mutual funds offer liquidity, allowing you to redeem units anytime, except for closed-ended and ELSS funds with lock-ins.

App Store